If you run a research agency, you already know the shape of the problem, because you live inside it. Clients want more studies, faster, across more markets, and they want to pay less for each one. Your cost base, meanwhile, won't bend. Every efficiency you can't find comes straight out of margin. That's the squeeze, and it's acute today, not coming.
The instinct is to grind harder, push the team, trim the scope, sharpen the pricing. But the squeeze isn't a discipline problem and it isn't your people. It's the legacy way of working, and that's the thing that actually has to change.
Two walls closing in
The pressure comes from both sides at once. On one side, demand is rising and accelerating. Clients are running more decisions across more markets in less time, and they push that pace down to you as "more, faster, cheaper." On the other side, budgets are flat or falling, so you can't simply raise the price to cover the extra load.
Caught between rising demand and flat budgets, the only variable left is your margin, and that's exactly what gets compressed. Work harder and you protect it for a quarter. The structural squeeze stays.
The cost is the complexity
Here's the part worth naming precisely. A single custom study crosses a sprawl of separate systems: a programming tool, a stack of panels, a fielding platform, fraud and quality checks, a weighting package, an open-end coding pass, and a charting and deck build. Each has its own license, its own hand-off, its own delay, and its own point of failure.
The labor that holds all that together, coordination, QA, rework, specialist time, is most of what a study actually costs. The complexity isn't a nuisance sitting around the cost. The complexity is the cost. Running research as a weeks-long relay across a dozen tools is no longer just slow; it's the thing eating your profitability.
And the ground underneath is shifting
On top of the operational strain, the tooling layer is itself unsettled. The dominant legacy lineage, Confirmit and FocusVision, now sits inside Forsta, which became part of a much larger consolidation when Qualtrics acquired Press Ganey Forsta for $6.75 billion, announced in late 2025 and closed in 2026. Reasonable people read that move differently, and we won't tell you what to conclude. But the practical effect for an agency is instability layered on top of complexity, at exactly the moment margins are thinnest.
The way out
You don't escape the squeeze by doing the same relay faster. You escape it by collapsing the relay. When every stage, design, programming, QA, fielding, data processing, weighting, coding, and reporting, runs on a single platform, the coordination labor between tools disappears and the cost falls with it. Same methodology, same rigor, roughly 80 percent less production cost and time, because what's removed is the manual work that inflated the price, not the expertise that justified it.
And the steps a platform like this absorbs are largely the ones you already send out, scripting, data processing, coding, charting. So it displaces external vendor spend, not your analysts. It's additive to how your team works, not a reorganization.
The villain is the relay, not your team
The squeeze is real and it's structural, but its source is specific. It's not your researchers, who are the value clients actually pay for. It's not a failure of effort. It's the legacy, multi-tool way of running a study, which made sense in a slower world and now quietly taxes every project you deliver. Collapse the operation into one platform and the squeeze loosens, because you've finally removed the thing that was causing it.